Skip to main content
Leiden University
Scholarly Publications
Home
Submit
About
Select Collection
All collections
Academic speeches
Dissertations
Faculty of Archaeology
Faculty of Governance and Global Affairs
Faculty of Humanities
Faculty of Science
Faculty of Social and Behavioural Sciences
Leiden Journals, Conference Proceedings and Books
Leiden Law School
Leiden University Press
Medicine / Leiden University Medical Centre (LUMC)
Research output UL
Search box
Your Search
Enabled Filters
(-)
= Alirocumab
Sort Options
Date (year)
Author / Creator
Title
Refine Results
Resource Type
Article / Letter to editor
(7)
+
-
Availability
Open access
(7)
+
-
Metadata Only
(1)
+
-
Creation Date
2020
(2)
+
-
2022
(2)
+
-
Faculty
Leiden University Medical Center (LUMC)
(6)
+
-
Collection
Medicine / Leiden University Medical Centre (LUMC)
(6)
+
-
Topic
Alirocumab
(8)
+
-
Acute coronary syndrome
(4)
+
-
Author
Goodman, S.G.
(7)
+
-
Jukema, J.W.
(7)
+
-
Pordy, R.
(7)
+
-
Schwartz, G.G.
(7)
+
-
Steg, P.G.
(7)
+
-
Szarek, M.
(7)
+
-
Bhatt, D.L.
(6)
+
-
Bittner, V.A.
(6)
+
-
Diaz, R.
(6)
+
-
ODYSSEY OUTCOMES Investigators
(6)
+
-
White, H.D.
(6)
+
-
Zeiher, A.M.
(5)
+
-
Chiang, C.E.
(3)
+
-
Harrington, R.A.
(3)
+
-
Loy, M.
(3)
+
-
Moriarty, P.M.
(3)
+
-
Alings, M.
(2)
+
-
Dilic, M.
(2)
+
-
Dorobantu, M.
(2)
+
-
Flores, R.M.C.
(2)
+
-
Fras, Z.
(2)
+
-
Halvorsen, S.
(2)
+
-
Manvelian, G.
(2)
+
-
McGinniss, J.
(2)
+
-
Pecin, I.
(2)
+
-
Poulsen, S.H.
(2)
+
-
Ray, K.K.
(2)
+
-
Ristic, A.D.
(2)
+
-
Roe, M.T.
(2)
+
-
Sinnaeve, P.
(2)
+
-
Sy, R.G.
(2)
+
-
Vogel, R.
(2)
+
-
Wojdyla, D.M.
(2)
+
-
Zahger, D.
(2)
+
-
Show more
Language
en
(8)
+
-
Search results
(1 - 8 of 8)
show grid
show list
save search
Effect of alirocumab on cataracts in patients with acute coronary syndromes
Relation of red blood cell distribution width to risk of major adverse cardiovascular events, death, and effect of alirocumab after acute coronary syndromes
Achievement of ESC/EAS LDL-C treatment goals after an acute coronary syndrome with statin and alirocumab
Alirocumab after acute coronary syndrome in patients with a history of heart failure
Lipoprotein(a) lowering by alirocumab reduces the total burden of cardiovascular events independent of low-density lipoprotein cholesterol lowering
Effect of alirocumab on cardiovascular outcomes after acute coronary syndromes according to age
Effects of alirocumab on types of myocardial infarction: insights from the ODYSSEY OUTCOMES trial
Innovative pharmaceutical interventions in experimental atherosclerosis : focusing on the contribution of non-HDL-C versus HDL-C